MAVCERTIX

Welcome to the Brand page for “MAVCERTIX”, which is offered here for Pharmaceutical preparations for the treatment of whim syndrome; pharmaceutical preparations for the treatment of immunodeficiencies; pharmaceutical preparations for the treatment of neutropenia; pharmaceutical preparations for the treatment of waldenström's macroglobulinemia; pharmaceutical preparations for the treatment of cancer;.

Its status is currently believed to be active. Its class is unavailable. “MAVCERTIX” is believed to be currently owned by “X4 Pharmaceuticals, Inc.”